Stock Events

Stock Events

SAB Biotherapeutics (SABS) Q1 2025 Earnings

2JanConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-1.19

-0.97

-0.76

-0.54

Details

Expected EPS

-1.164

Actual EPS

-1.185

Surprise EPS

-0.02

Surprise Percent

+1.8%

Description

SAB Biotherapeutics (SABS) has reported earnings of -1.185 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.